Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Liquid Biopsy and Cancer Interception Group, |
RCV003129624 | SCV003806321 | pathogenic | Lung adenocarcinoma | 2022-06-06 | criteria provided, single submitter | research | |
Myriad Genetics, |
RCV004245991 | SCV004931691 | pathogenic | Li-Fraumeni syndrome 1 | 2024-02-21 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |